Effect of Antituberculosis Drug Resistance on Response to Treatment and Outcome in Adults with Tuberculous Meningitis
Author(s) -
Guy Thwaites,
Nguyễn Thị Ngọc Lan,
Nguyen Huy Dung,
Hoang Thi Quy,
Do Thi Tuong Oanh,
Nguyen Thi Cam Thoa,
Nguyen Quang Hien,
Nguyen Tri Thuc,
Nguyễn Ngọc Hải,
Nguyen Duc Bang,
NgocLan Nguyen,
Nguyen Hong Duc,
Vu Ngoc Tuan,
Cao Huu Hiep,
Tran Thi Hong Chau,
Pham Phuong,
Thị Dung Nguyễn,
Kasia Stepniewska,
Nicholas J. White,
Tran Tinh Hien,
Jeremy Farrar
Publication year - 2005
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/430616
Subject(s) - isoniazid , medicine , rifampicin , tuberculous meningitis , tuberculosis , streptomycin , pyrazinamide , drug resistance , mycobacterium tuberculosis , meningitis , antibiotics , immunology , surgery , microbiology and biotechnology , biology , pathology
Tuberculous meningitis (TBM) caused by Mycobacterium tuberculosis resistant to 1 or more antituberculosis drugs is an increasingly common clinical problem, although the impact on outcome is uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom